Association between metabolic disease and cardiovascular risk in patients with schizophrenia treated with antipsychotics

被引：0
|
作者：
Vataire, A. [1 ]
Ferchichi, S. [1 ]
Desroziers, K. [1 ]
Cadi-Soussi, N. [2 ]
Murthy, V. [3 ]
Toumi, M. [4 ]
机构：
[1] Creativ Ceut, Paris, France
[2] Takeda Pharmaceut Int GmbH, Zurich, Switzerland
[3] Takeda Dev Ctr Europe, London, England
[4] Univ Lyon 1, F-69365 Lyon, France
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2013年 / 23卷
关键词：
D O I：
10.1016/S0924-977X(13)70785-5
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.3.f.007
引用
收藏
页码：S495 / S495
页数：1
相关论文
共 50 条
  • [31] Investigation of the metabolic effects of antipsychotics in patients with schizophrenia
    Chue, P
    Welch, R
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S300 - S300
  • [32] A study of the metabolic effects of antipsychotics in patients with schizophrenia
    Chue, P
    Welch, R
    Lind, J
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S424 - S424
  • [33] Decreased cardiovascular death in schizophrenia patients treated with antipsychotics: A Korean national cohort study
    Oh, Jihoon
    Nam, Hyewon
    Park, Sangmin
    Chae, Jeong-Ho
    Kim, Tae-Suk
    SCHIZOPHRENIA RESEARCH, 2021, 228 : 417 - 424
  • [34] Prevalence of metabolic syndrome among schizophrenia patients treated with monotherapy atypical antipsychotics in Malaysia
    Sulaiman, A. H.
    Said, M. A.
    Habil, M. H.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 136 - 136
  • [35] Cytokine Level Changes in Schizophrenia Patients with and without Metabolic Syndrome Treated with Atypical Antipsychotics
    Boiko, Anastasiia S.
    Mednova, Irina A.
    Kornetova, Elena G.
    Gerasimova, Valeria I.
    Kornetov, Alexander N.
    Loonen, Anton J. M.
    Bokhan, Nikolay A.
    Ivanova, Svetlana A.
    PHARMACEUTICALS, 2021, 14 (05)
  • [36] DYSLIPIDEMIA IN PSYCHIATRIC PATIENTS WITH SCHIZOPHRENIA, TREATED WITH ANTIPSYCHOTICS
    Ladea, M.
    Exergian, A. M.
    Barbu, C. M.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2013, 9 (04) : 647 - 653
  • [37] SEXUAL DYSFUNCTION IN PATIENTS WITH SCHIZOPHRENIA TREATED WITH ANTIPSYCHOTICS
    Mendonca, C.
    Bras, A.
    EUROPEAN PSYCHIATRY, 2013, 28
  • [38] Associations between the number of antipsychotics prescribed and metabolic parameters in Japanese patients with schizophrenia
    Watanabe, Yuichiro
    Ono, Shin
    Sugai, Takuro
    Suzuki, Yutaro
    Yamazaki, Manabu
    Sugawara, Norio
    Yasui-Furukori, Norio
    Shimoda, Kazutaka
    Mori, Takao
    Ozeki, Yuji
    Matsuda, Hiroshi
    Okamoto, Kurefu
    Sagae, Toyoaki
    Someya, Toshiyuki
    PSYCHIATRY AND CLINICAL NEUROSCIENCES REPORTS, 2022, 1 (03):
  • [39] Comparison of metabolic changes between patients with schizophrenia taking clozapine and the other antipsychotics
    Lee, N. Y.
    Kim, S. H.
    Shin, S. Y.
    Ahn, Y. M.
    Kang, U. G.
    Youn, T.
    Chung, I. W.
    Kim, Y. S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S335 - S335
  • [40] Association of hsCRP with High-Risk of Cardiovascular Disease in Patients with Early Course Schizophrenia
    Yao, Jeffrey K.
    Reddy, Ravinder D.
    Doughedy, George G.
    Magan, Sharon
    Gurklis, John
    Sonel, Ali
    Sonel, Elif
    Kisslinger, Benjamin L.
    Chengappa, Roy K. N.
    Keshavan, Matcheri S.
    BIOLOGICAL PSYCHIATRY, 2012, 71 (08) : 168S - 169S
12345